Teresa De Luca Surgery Partners, Inc. (SGRY) insider trading activity

Teresa De Luca is Director of Surgery Partners, Inc.. Currently has a direct ownership of 45,173 shares of SGRY, which is worth approximately $1.04 Million. The most recent transaction as insider was on Aug 11, 2025, when has been sold 20,018 shares (Common Stock) at a price of $22.74 per share, resulting in proceeds of $455,209. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 45.2K

22.56% 3M change

22.56% 12M change

Total Value Held $1.04 Million

Teresa DeLuca Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 11 2025	SELL Open market or private sale	$455,209 $22.74 p/Share	20,018 Reduced 30.71%	45,173 Common Stock
Jun 10 2025	BUY Grant, award, or other acquisition	$159,998 $23.32 p/Share	6,861 Added 9.52%	65,191 Common Stock
Jun 06 2024	BUY Grant, award, or other acquisition	$159,988 $25.93 p/Share	6,170 Added 9.57%	58,330 Common Stock
Jun 01 2023	BUY Grant, award, or other acquisition	$159,966 $38.16 p/Share	4,192 Added 7.44%	52,160 Common Stock
Nov 21 2022	BUY Open market or private purchase	$490,000 $24.5 p/Share	20,000 Added 29.43%	47,968 Common Stock
May 20 2022	BUY Grant, award, or other acquisition	$159,991 $39.7 p/Share	4,030 Added 12.59%	27,968 Common Stock
Mar 24 2022	SELL Open market or private sale	$82,122 $53.5 p/Share	1,535 Reduced 6.03%	23,938 Common Stock
Aug 10 2021	BUY Open market or private purchase	$93,400 $46.7 p/Share	2,000 Added 7.28%	25,473 Common Stock
Jun 09 2021	SELL Open market or private sale	$320,578 $63.67 p/Share	5,035 Reduced 17.66%	23,473 Common Stock
Jun 08 2021	SELL Open market or private sale	$166,011 $63.05 p/Share	2,633 Reduced 8.46%	28,508 Common Stock
Mar 10 2021	BUY Grant, award, or other acquisition	-	3,330 Added 9.66%	31,141 Common Stock
Dec 14 2020	SELL Open market or private sale	$27,150 $27.15 p/Share	1,000 Reduced 3.47%	27,811 Common Stock
Dec 04 2020	SELL Open market or private sale	$25,391 $27.75 p/Share	915 Reduced 3.08%	28,811 Common Stock
Dec 01 2020	SELL Payment of exercise price or tax liability	$84,990 $25.88 p/Share	3,284 Reduced 9.95%	29,726 Common Stock
Dec 01 2020	BUY Exercise of conversion of derivative security	$84,988 $20.24 p/Share	4,199 Added 11.28%	33,010 Common Stock

Also insider at

ATNF

180 Life Sciences Corp. Healthcare

Director

LFST

LifeStance Health Group, Inc. Healthcare

Teresa De Luca

Director

Palo Alto, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SGRY shares.

Notify only if

Value

Insider Trading

Get notified when an Surgery Partners, Inc. insider buys or sells SGRY shares.

Notify only if

Operation

Value

Type

News

Receive news related to Surgery Partners, Inc.

Track Activities on SGRY

Account